rolipram has been researched along with Anemia, Sickle Cell in 1 studies
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Franceschi, L | 1 |
| Platt, OS | 1 |
| Malpeli, G | 1 |
| Janin, A | 1 |
| Scarpa, A | 1 |
| Leboeuf, C | 1 |
| Beuzard, Y | 1 |
| Payen, E | 1 |
| Brugnara, C | 1 |
1 other study available for rolipram and Anemia, Sickle Cell
| Article | Year |
|---|---|
Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell mice.
Topics: Anemia, Sickle Cell; Animals; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Mice; Mice, | 2008 |